J. Mark FitzGerald

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Immunology, Pharmacology +17

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow et al. · The Lancet Respiratory Medicine · 2017 · 317 citations

Medicine, Immunology, Pharmacology +13

Antibiotic Use in Children Is Associated With Increased Risk of Asthma

Fawziah Marra, Carlo A. Marra, Kathryn Richardson et al. · PEDIATRICS · 2009 · 284 citations

Public Health, Child Health, Pediatrics +7

Bronchial Thermoplasty for Asthma

Gerard Cox, John D. Miller, Annette McWilliams et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 279 citations

Medicine, Clinical Sciences, Internal Medicine +17